Patent details

Basic Information

Publication number:

EP3626258

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191926799

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

French Title of Invention:

PROCÉDÉS ET COMPOSITIONS POUR L'ADMINISTRATION D'IDURONATE-2-SULFATASE AU SYSTÈME NERVEUX CENTRAL

German Title of Invention:

VERFAHREN UND ZUSAMMENSETZUNGEN ZUR ZNS-ABGABE VON IDURONAT-2-SULFATASE

SPC Number:

Dates

Filing date:

25/06/2011

Grant date:

04/08/2021

EP Publication Date:

25/03/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/08/2021

EP B1 Publication Date:

04/08/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

25/06/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/07/2023

 

 

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

History of Owners

From:

28/07/2021

To:

14/07/2023

Name:

Shire Human Genetic Therapies, Inc.

Address:

300 Shire Way, Lexington MA 02421, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

02/09/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WRIGHT, Teresa, Leah

Address:

United States (US)

2

Name:

LOWE, Kris

Address:

United States (US)

3

Name:

PAN, Jing

Address:

United States (US)

4

Name:

ZHU, Gaozhong

Address:

United States (US)

5

Name:

CHRISTIAN, James

Address:

United States (US)

6

Name:

CALIAS, Pericles

Address:

United States (US)

7

Name:

FAHRNER, Rick

Address:

United States (US)

8

Name:

SHAHROKH, Zahra

Address:

United States (US)

Priority

1

Priority Number:

35885710 P

Priority Date:

25/06/2010

Priority Country:

United States (US)

2

Priority Number:

36078610 P

Priority Date:

01/07/2010

Priority Country:

United States (US)

3

Priority Number:

38786210 P

Priority Date:

29/09/2010

Priority Country:

United States (US)

4

Priority Number:

201161435710 P

Priority Date:

24/01/2011

Priority Country:

United States (US)

5

Priority Number:

201161442115 P

Priority Date:

11/02/2011

Priority Country:

United States (US)

6

Priority Number:

201161476210 P

Priority Date:

15/04/2011

Priority Country:

United States (US)

7

Priority Number:

201161495268 P

Priority Date:

09/06/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/47; A61P 25/00; A61P 25/28; A61K 9/19; A61K 38/46;

Publication

European Patent Bulletin

1

Issue number:

202131

Publication date:

04/08/2021

Description:

Grant (B1)

2

Issue number:

202135

Publication date:

01/09/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:

202333

Publication date:

16/08/2023

Description:

Transfer of Rights

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

21/05/2024

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
02/09/2021	Power Of Attorney	1
02/09/2018	Outgoing Correspondence	1